Literature DB >> 1899428

Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus.

A W Thorburn1, B Gumbiner, F Bulacan, G Brechtel, R R Henry.   

Abstract

To define the mechanisms of impaired muscle glycogen synthase and reduced glycogen formation in non-insulin dependent diabetes mellitus (NIDDM), glycogen synthase activity was kinetically analyzed during the basal state and three glucose clamp studies (insulin approximately equal to 300, 700, and 33,400 pmol/liter) in eight matched nonobese NIDDM and eight control subjects. Muscle glycogen content was measured in the basal state and following clamps at insulin levels of 33,400 pmol/liter. NIDDM subjects had glucose uptake matched to controls in each clamp by raising serum glucose to 15-20 mmol/liter. The insulin concentration required to half-maximally activate glycogen synthase (ED50) was approximately fourfold greater for NIDDM than control subjects (1,004 +/- 264 vs. 257 +/- 110 pmol/liter, P less than 0.02) but the maximal insulin effect was similar. Total glycogen synthase activity was reduced approximately 38% and glycogen content was approximately 30% lower in NIDDM. A positive correlation was present between glycogen content and glycogen synthase activity (r = 0.51, P less than 0.01). In summary, defects in muscle glycogen synthase activity and reduced glycogen content are present in NIDDM. NIDDM subjects also have less total glycogen synthase activity consistent with reduced functional mass of the enzyme. These findings and the correlation between glycogen synthase activity and glycogen content support the theory that multiple defects in glycogen synthase activity combine to cause reduced glycogen formation in NIDDM.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899428      PMCID: PMC296335          DOI: 10.1172/JCI115022

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  GLYCOGEN SYNTHETASE ACTIVITY IN SKELETAL MUSCLE. INTERCONVERSION OF TWO FORMS AND CONTROL OF GLYCOGEN SYNTHESIS.

Authors:  W H DANFORTH
Journal:  J Biol Chem       Date:  1965-02       Impact factor: 5.157

2.  Influences of glucose loading and of injected insulin on hepatic glucose output.

Authors:  R STEELE
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 4.  Gluconeogenesis: methodological approaches in vivo.

Authors:  J L Chiasson; J E Liljenquist; W W Lacy; A S Jennings; A D Cherrington
Journal:  Fed Proc       Date:  1977-02

Review 5.  Insulin-signaling mechanisms. Lessons from the old testament of glycogen metabolism and the new testament of molecular biology.

Authors:  J Larner
Journal:  Diabetes       Date:  1988-03       Impact factor: 9.461

6.  Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM.

Authors:  R R Henry; B Gumbiner; T Flynn; A W Thorburn
Journal:  Diabetes       Date:  1990-02       Impact factor: 9.461

7.  Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle.

Authors:  H Yki-Järvinen; D Mott; A A Young; K Stone; C Bogardus
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

8.  Effect of hyperinsulinemia and hyperglycemia on intracellular glucose and fat metabolism in healthy subjects.

Authors:  A W Thorburn; B Gumbiner; G Brechtel; R R Henry
Journal:  Diabetes       Date:  1990-01       Impact factor: 9.461

9.  Glucose-6-phosphate stimulation of human muscle glycogen synthase phosphatase.

Authors:  M Okubo; C Bogardus; S Lillioja; D M Mott
Journal:  Metabolism       Date:  1988-12       Impact factor: 8.694

10.  Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patients.

Authors:  J F Bak; O Schmitz; N S Sørensen; O Pedersen
Journal:  Diabetes       Date:  1989-11       Impact factor: 9.461

View more
  28 in total

1.  Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.

Authors:  H Vestergaard; S Lund; C Bjørbaek; O Pedersen
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

2.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 3.  Myocardial autophagic energy stress responses--macroautophagy, mitophagy, and glycophagy.

Authors:  Lea M D Delbridge; Kimberley M Mellor; David J R Taylor; Roberta A Gottlieb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-06       Impact factor: 4.733

4.  Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  A Vaag; P Damsbo; O Hother-Nielsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

5.  Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.

Authors:  A Vaag; J E Henriksen; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

6.  Mechanisms of fatty acid-induced inhibition of glucose uptake.

Authors:  G Boden; X Chen; J Ruiz; J V White; L Rossetti
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Multiple lipolysis defects in the insulin resistance (metabolic) syndrome.

Authors:  S Reynisdottir; K Ellerfeldt; H Wahrenberg; H Lithell; P Arner
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.

Authors:  R C Bonadonna; S Del Prato; M P Saccomani; E Bonora; G Gulli; E Ferrannini; D Bier; C Cobelli; R A DeFronzo
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man.

Authors:  P Ebeling; V A Koivisto
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

10.  Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin.

Authors:  V Sarabia; L Lam; E Burdett; L A Leiter; A Klip
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.